Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

MYGNMYGN
9 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in MYRIAD GENETICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 1.9M shares of MYGN (MYRIAD GENETICS INC), worth $10.8M as of 2026-Q2. The position was decreased (-9.4% shares). MYGN represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$10.8M

Current Shares

1.9M

Total Value Change

+$9.3M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.9M
-9.4%
$10.8M0.0%$5.71
0
2026-Q1
Decreased
2.1M
-8.0%
$9.4M0.0%$5.29
0
2025-Q4
Decreased
2.3M
-7.1%
$14M0.1%$6.17
0
2025-Q3
Increased
2.4M
+157.0%
$17.7M0.1%$7.24
46
2025-Q2
New
950,507
-
$5M0.0%$5.25
37
2021-Q1
Exited
0
-100.0%
$00.0%$29.16
0
2020-Q4
Decreased
62,922
-91.9%
$1.2M0.0%$19.63
0
2020-Q3
Increased
774,489
+498.6%
$10.1M0.1%$12.74
53
2020-Q2
New
129,373
-
$1.5M0.0%$11.02
35

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used